In brief

Dexco narrowed its recurring loss to R$ 5.5 million in 3Q26.

Adjusted Ebitda rose 31.6%.

What we know

04
  1. Verified fact · material

    Dexco posted a recurring net loss of about R$ 5.5 million in 3Q26, down 87% from 3Q25.

    Recurring.

    Sources[01][02]
  2. Verified fact · material

    Adjusted Ebitda was R$ 585.4 million, up 31.6% in a year.

    Ebitda.

    Sources[01][02]
  3. Verified fact

    According to Money Times, the reported loss was R$ 142 million, with R$ 136.7 million in one-offs.

    Reported.

    Sources[02]
  4. Verified fact

    According to Money Times, Dexco posted net income of R$ 14.2 million in 3Q25.

    Base.

    Sources[02]

Transmission to assets

Market read-through

Operating improvement contrasts with the reported loss from plant closures.

Portfolio impact

01
DXCO3positive

Operations improve.

High rates.

What would change the view: Firm demand.

direct10% confidence

Direction is an explanatory hypothesis, not a forecast or recommendation.

Next signals

What to watch

  • Restructuring
  • Building materials demand

Limits of the reporting

What remains uncertain

  • The reported loss appears in only one source.

Full sources

02